未知股票 SANW 深 滬
已收盤
--
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 --
- 最 低 --
- 昨 收 --
- 總市值 0
- 52周最高 --
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 214.68万
- 歷史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 --
- 每 手 1
- 風險率 2.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sanuwave Health to Present at Canaccord Genuity Growth Conference
Sanuwave Health, Inc. announced that its CEO, Morgan Frank, will present at the 45th Annual Canaccord Genuity Growth Conference in Boston on August 12–13, 2025. The presentation is scheduled for August 13, from 9:30 to 9:55 a.m. ET. Mr. Frank will also be available for one-on-one investor meetings during the conference. Sanuwave focuses on developing non-invasive, FDA-approved wound care products aimed at promoting tissue repair and regeneration.
2025-07-22 20:05
S&W Seed Faces Collateral Sale Amid Financial Distress
S&W Seed Company ( ($SANW) ) has shared an announcement. On June 17, 2025, ...
2025-07-18 05:48
S&W Seed Company Delists from Nasdaq
The latest update is out from S&W Seed Company ( ($SANW) ). On July 8, 2025...
2025-07-15 04:58
S&W Announces Voluntary Delisting from Nasdaq and SEC Deregistration
S&W Seed Company announced its board approved the voluntary delisting of its common stock from the Nasdaq Capital Market and deregistration with the SEC to suspend reporting obligations under the Securities Exchange Act of 1934. The company intends to file Form 25 by July 24, 2025, and Form 15 by August 4, 2025. This decision follows likely non-compliance with Nasdaq's listing requirements, high costs, and regulatory burdens. The company's stock ...
2025-07-14 20:30
Top 3 Risk Off Stocks That May Rocket Higher In Q3
The most oversold stocks in the consumer staples sector presents an opportunity...
2025-07-09 20:18
美股大行评级 | 潜在涨幅2840.31%！Mersana Therapeutics获Truist Securities升目标价至10美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130419824951111681.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Truist Securities：维持Mersana Therapeutics(MRSN)"买入"评级，目标价从9美元升至10美元</p> <p>• Guggenheim：维持Cabaletta Bio(CABA)"买入
2025-05-17 08:44
Lake Street Maintains Buy on S&W Seed, Lowers Price Target to $25
Lake Street analyst Ben Klieve maintains S&W Seed (NASDAQ:SANW) with a Buy and lowers the price target from $35 to $25.
2025-05-17 05:27
S&W Seed Lowers FY2025 Sales Guidance from $34.50M-$38.00M to $29.00M-$31.00M vs $35.89M Est
Fiscal 2025 GuidanceThe Company is updating its expectations for fiscal 2025 revenue to be in the range of $29.0 to $31.0 million. The change in expectations is primarily due to expected continuing disruptions within the
2025-05-15 20:04
